Curanex Pharmaceuticals Inc CURX
6.09 USD -0.11 (-1.77%)
At closeNov 10, 2026, 4:00 PM EST
6.09 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
5.82 Day range 6.09
3.66 52-week range 11.90
- YTD
- -8.01%
- 1 year
- -48.04%
- Market cap
- 9.55M
- EPS (ttm)
- -7.63
- YTD return
- -8.01%
- 1-year return
- -48.04%
- Volume
- 2.01K
- Avg volume
- 21.85K
- Open
- 5.82
- Previous close
- 6.20
- Day's range
- 5.82 – 6.09
- 52-week range
- 3.66 – 11.90
5D +0.21 (+3.57%)
Financials — quick view
CURX Revenue — quarterly 0
CURX Net income — quarterly -3.29M
CURX EPS — quarterly -2.40
News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) 
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) 
Curanex Pharmaceuticals Q1 EPS $(0.11) Down From $(0.01) YoY - Curanex Continues To Advance Phyto-N As Lead Development Candidate, With Ulcerative Colitis As Initial Target Indication; Co. Prepares Phyto-N For Planned IND Submission In Q4 Of 2026
Your note
Sign in to keep a note on CURX — it syncs with the Stock Master app.